Ternium Argentina Heads Into Q3 Print With Momentum at Its Back

TXAR reports its Q3 2026 results today with the stock up 16% over the past month, a sharp recovery that frames the question investors will want answered: whether the underlying business can support the move.

The price action tells a divided story. The monthly gain has stalled into the print, with TXAR slipping 3% on the week before recovering 3% on Thursday to close at ARS 745. Parent group Ternium, listed in New York as TX, edged up 0.3% on the day but is also down around 2% on the week, suggesting the broader Ternium complex is not driving fresh enthusiasm. Closest Buenos Aires peer ALUA gained 2.6% Thursday but is only up 1.2% on the week, so TXAR's recent underperformance appears partly stock-specific rather than purely sectoral.

The bull and bear cases are straightforward to frame. Bulls point to a valuation that looks compressed even after the recent rally: the stock trades at a PE of around 3.1 and an EV/EBITDA of roughly 3.6, both on the lower end for an integrated steelmaker, alongside a price-to-book of roughly 0.87. The dividend yield adds to the value argument, with ORTEX factor scores ranking TXAR in the 79th percentile on dividend quality. Bears focus on the structural challenge: peso volatility erodes the real value of local revenues, global steel demand remains soft, and recent notes point to margin pressure that has not yet fully resolved. The ORTEX stock score sits at 78.2 with Growth the leading pillar at 85.1, but Momentum at 55.0 reflects the prolonged underperformance that preceded this recovery.

Ownership is highly concentrated, with Rocca and Partners holding 62.6% of shares as of end-2025, meaning the free float is thin. That limits the signal from most positioning metrics: lending market data is stale and not usable, and short interest is not a meaningful variable here. What matters is whether the quarterly figures demonstrate that margins held through the peso weakness and that volume trends support the growth score's optimism.

The print will test whether TXAR's 16% monthly recovery is anchored in an earnings trajectory that justifies the move, or whether the stock ran ahead of fundamentals that a difficult Argentine operating environment has yet to deliver.